The gene-editing powerhouse the merger between Bayer and Monsanto could produce has been less discussed in media and investment circles, but is a major part of the transaction, writes Emma Cowan.
Is it possible that genetically modified crops are on the road to redemption in Europe? It looks like Bayer might think so after its recent offer to acquire Monsanto, writes Emma Cowan.
An urgency within the industry to merge or acquire has been palpable with discussions ongoing between apparently all of the major players, writes Emma Cowan, founder of agribusiness consultancy Cardy-Brown.
